U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C22H20FN3OS
Molecular Weight 393.477
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Tifluadom

SMILES

CN1C(CNC(=O)C2=CSC=C2)CN=C(C3=CC=CC=C3F)C4=CC=CC=C14

InChI

InChIKey=NPGABYHTDVGGJK-UHFFFAOYSA-N
InChI=1S/C22H20FN3OS/c1-26-16(13-25-22(27)15-10-11-28-14-15)12-24-21(17-6-2-4-8-19(17)23)18-7-3-5-9-20(18)26/h2-11,14,16H,12-13H2,1H3,(H,25,27)

HIDE SMILES / InChI

Molecular Formula C22H20FN3OS
Molecular Weight 393.477
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Tifluadom is an opioid benzodiazepine with potent analgesic activity. Studies using antagonists for κ-, δ-, and μ-opiate receptors in guinea pig myenteric plexus-longitudinal muscle preparation and mouse and rabbit vasa deferentia showed that Tifluadom is an opioid analgesic with a preference for opiate κ-receptors. In rat brain homogenates, tifluadom displaced kappa-antagonist naloxone from its binding sites with an IC50 of 12nM but had no effect on flunitrazepam binding. Tifluadom produced a dose-related diuresis in normally hydrated rats and the diuretic effect was antagonized by naloxone and blocked by morphine administration.

Approval Year

PubMed

PubMed

TitleDatePubMed
Unexpected opioid activity in a known class of drug.
1982 Sep 20-27
Studies on the adrenomedullary dependence of kappa-opioid agonist-induced diuresis in conscious rats.
1989 Dec
Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
1997 Aug
Patents

Patents

Sample Use Guides

Dog: 5, 10, 20, 40, 80 micrograms/kg
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:45:00 GMT 2023
Edited
by admin
on Sat Dec 16 16:45:00 GMT 2023
Record UNII
TF8X866L0I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Tifluadom
INN  
INN  
Official Name English
(±)-N-((5-(O-FLUOROPHENYL)-2,3-DIHYDRO-1-METHYL-1H-1,4-BENZODIAZEPIN-2-YL)METHYL)-3-THIOPHENECARBOXAMIDE
Common Name English
tifluadom [INN]
Common Name English
KC-5103
Code English
Classification Tree Code System Code
NCI_THESAURUS C67413
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C91053
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
CAS
81656-30-6
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
SUPERSEDED
FDA UNII
TF8X866L0I
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
CAS
83386-35-0
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
EPA CompTox
DTXSID40868621
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
INN
5267
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
WIKIPEDIA
TIFLUADOM
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
PUBCHEM
115208
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
MESH
C035470
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
SMS_ID
100000082652
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
ECHA (EC/EINECS)
280-380-4
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
EVMPD
SUB11042MIG
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
ChEMBL
CHEMBL169703
Created by admin on Sat Dec 16 16:45:00 GMT 2023 , Edited by admin on Sat Dec 16 16:45:00 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE ENANTIOMER->RACEMATE
TARGET -> INHIBITOR
TARGET -> AGONIST
Ki
Related Record Type Details
ACTIVE MOIETY